Canada Life’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Canada Life’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,406	Closed	-$48K	–	2571
2021 Q2	$48K	Hold	1,406	–	–	﹤0.01%	2288
2021 Q1	$33K	Hold	1,406	–	–	﹤0.01%	2421
2020 Q4	$40K	Hold	1,406	–	–	﹤0.01%	2364
2020 Q3	$28K	Hold	1,406	–	–	﹤0.01%	2355
2020 Q2	$42K	Buy	+1,406	New	+$50.6K	﹤0.01%	2275

Canada Life's CNST Position: Q3 2021 in Review

Canada Life sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,406 shares — an estimated $48K sold.

Canada Life first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $48K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Canada Life reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Canada Life sold 1,406 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $48K.
Canada Life first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
Canada Life's Constellation Pharmaceuticals, Inc. position peaked at $48K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Canada Life's 13F filing for Q3 2021, filed 15 Nov 2021.